Clinical Trial Update: Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial of a dendritic cell vaccine with chemotherapy for pancreatic cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Dendritic cell vaccine

Snippet

Sponsor: Baylor Research Institute | Conditions: Pancreatic Cancer | Phase 1 | Status: TERMINATED